To access the data, click or select the words “Appendix 2.” Assessment of viability of ARPE-19 cells (MTT assay) upon treatment with iHA-VMA and VMA. ARPE-19 cells were viable up to 80 nU/µl of iHA-VMA and VMA (NS: not significant).